Smoking cessation strategies for patients with asthma: Improving patient outcomes

Journal of Asthma and Allergy

Volumn 9, Issue , 2016, Pages 117-128

  Perret, Jennifer L ^a,b,c   Bonevski, Billie ^d   McDonald, Christine F ^a,b,c   Abramson, Michael J ^e,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f ALFRED HOSPITAL   (Australia)

Author keywords

ACOS; Asthma; Asthma COPD overlap syndrome; Lung function; Patient outcomes; Smoking cessation

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ADVERSE OUTCOME; ASTHMA; AUSTRALIA; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; CONSUMER HEALTH INFORMATION; ELECTRONIC CIGARETTE; HUMAN; INTERNET; LUNG FUNCTION; MOBILE PHONE; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PARENTAL SMOKING; PATIENT EDUCATION; PREVALENCE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMINDER SYSTEM; REVIEW; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM;

EID: 84978715596     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S85615     Document Type: Review

References (103)

1. Cancer Institute NSW. New South Wales Smoking and Health Survey 2009. Sydney: Cancer Institute NSW; 2009.
2. Bush T, Zbikowski SM, Mahoney L, Deprey M, Mowery P, Cerutti B. State quitlines and cessation patterns among adults with selected chronic diseases in 15 states, 2005-2008. Prev Chronic Dis. 2012; 9: 120105.
3. McLeish AC, Johnson AL, Avallone KM, Zvolensky MJ. Evaluating the role of anxiety sensitivity in barriers to cessation and reasons for quitting among smokers with asthma. Psychol Health Med. 2015: 1-12.
4. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004; 24 (5): 822-833.
5. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011; 105 (3): 477-484.
6. Jimenez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015; 46 (1): 61-79.
7. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol. 2012; 158 (2): 175-183.
8. Zbikowski SM, Klesges RC, Robinson LA, Alfano CM. Risk factors for smoking among adolescents with asthma. J Adolesc Health. 2002; 30 (4): 279-287.
9. Van de Ven MO, Engels RC, Kerstjens HA, Van den Eijnden RJ. Bidirectionality in the relationship between asthma and smoking in adolescents: a population-based cohort study. J Adolesc Health. 2007; 41 (5): 444-454.
10. Tercyak KP. Brief report: social risk factors predict cigarette smoking progression among adolescents with asthma. J Pediatr Psychol. 2006; 31 (3): 246-251.
11. Precht DH, Keiding L, Madsen M. Smoking patterns among adolescents with asthma attending upper secondary schools: a communitybased study. Pediatrics. 2003; 111 (5 pt 1): e562-e568.
12. Wakefield M, Ruffin R, Campbell D, Roberts L, Wilson D. Smokingrelated beliefs and behaviour among adults with asthma in a representative population sample. Aust N Z J Med. 1995; 25 (1): 12-17.
13. van Zundert RM, Engels RC, Kleinjan M, van den Eijnden RJ. An integration of parents’ and best friends’ smoking, smoking-specific cognitions, and nicotine dependence in relation to readiness to quit smoking: a comparison between adolescents with and without asthma. J Pediatr Psychol. 2008; 33 (8): 821-832.
14. Avallone KM, McLeish AC, Zvolensky MJ, Kraemer KM, Luberto CM, Jeffries ER. Asthma and its relation to smoking behavior and cessation motives among adult daily smokers. J Health Psychol. 2013; 18 (6): 788-799.
15. Nelson KE, Hersh AL, Nkoy FL, Maselli JH, Srivastava R, Cabana MD. Primary care physician smoking screening and counseling for patients with chronic disease. Prev Med. 2015; 71: 77-82.
16. Gratziou C, Florou A, Ischaki E, et al. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions. Respir Med. 2014; 108 (4): 577-583.
17. Leone FT, Ferkol TW. Such are the impositions of Quackery: Ecigarettes. Ann Am Thorac Soc. 2015; 12 (6): 787-788.
18. Center for Health Promotion and Education [webpage on the Internet]. The Health Consequences of Smoking, Nicotine Addiction: A Report of the Surgeon General. 1988. Available from: http: //profiles.nlm.nih. gov/NN/B/B/Z/D. Accessed August 1, 2015.
19. Van De Ven MO, van Zundert RM, Engels RC. Effects of asthma on nicotine dependence development and smoking cessation attempts in adolescence. J Asthma. 2013; 50 (3): 250-259.
20. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med. 2013; 187 (1): 42-48.
21. Perret JL, Walters EH, Abramson MJ, McDonald CF, Dharmage SC. The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD. Expert Rev Respir Med. 2014; 8 (4): 503-514.
22. Bize R, Burnand B, Mueller Y, Rege-Walther M, Camain JY, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2012; 12: CD004705.
23. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008; 336 (7644): 598-600.
24. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013; 368 (4): 341-350.
25. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009; 15 (1): 39-45.
26. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy. 2008; 63 (1): 132-135.
27. Boulet LP, FitzGerald JM, McIvor RA, Zimmerman S, Chapman KR. Influence of current or former smoking on asthma management and control. Can Respir J. 2008; 15 (5): 275-279.
28. To T, Daly C, Feldman R, McLimont S. Results from a communitybased program evaluating the effect of changing smoking status on asthma symptom control. BMC Public Health. 2012; 12: 293.
29. Thomson NC, Chaudhuri R, Heaney LG, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol. 2013; 131 (4): 1008-1016.
30. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007; 175 (8): 783-790.
31. Chinn S, Jarvis D, Luczynska CM, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med. 2005; 172 (8): 956-961.
32. Zheng X, Guan W, Zheng J, et al. Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis. Curr Med Res Opin. 2012; 28 (11): 1791-1798.
33. Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest. 2008; 134 (2): 394-401.
34. Clearie KL, McKinlay L, Williamson PA, Lipworth BJ. Fluticasone/ Salmeterol combination confers benefits in people with asthma who smoke. Chest. 2012; 141 (2): 330-338.
35. Price D, Bjermer L, Popov TA, Chisholm A. Integrating evidence for managing asthma in patients who smoke. Allergy Asthma Immunol Res. 2014; 6 (2): 114-120.
36. McLeish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma. 2010; 47 (4): 345-361.
37. Godtfredsen NS, Lange P, Prescott E, Osler M, Vestbo J. Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J. 2001; 18 (3): 549-554.
38. Comhair SA, Gaston BM, Ricci KS, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One. 2011; 6 (5): e18574.
39. Sims M, Maxwell R, Gilmore A. Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study. Thorax. 2013; 68 (7): 619-624.
40. Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med. 2006; 173 (9): 953-957.
41. Armour CL, Lemay K, Saini B, et al. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma. 2011; 48 (9): 914-922.
42. Robinson DS, Campbell DA, Durham SR, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J. 2003; 22 (3): 478-483.
43. Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015; 46 (3): 622-639.
44. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol. 2002; 109 (2): 189-194.
45. Tai A, Tran H, Roberts M, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol. 2014; 133 (6): 1572e-1578e.
46. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998; 339 (17): 1194-1200.
47. Miravitlles M, Calle M, Soler-Cataluna JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012; 48 (3): 86-98.
48. Global Strategy for Asthma Management and Prevention [homepage on the Internet]. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). 2014. Available from: http//www.ginasthma.org. Accessed October 15, 2014.
49. Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013; 6 (2): 197-219.
50. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011; 12: 127.
51. U. S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. Atlanta, GA: U. S. Department of Health and Human Services; 2014.
52. Samet JM. The surgeon generals’ reports and respiratory diseases. From 1964 to 2014. Ann Am Thorac Soc. 2014; 11 (2): 141-148.
53. Hurt RD, Berge KG, Offord KP, et al. The making of a smoke-free medical center. JAMA. 1989; 261 (1): 95-97.
54. Scollo MM, Winstanley MH [homepage on the Internet]. Tobacco in Australia: Facts and issues. Melbourne: Cancer Council Victoria; 2015. Available from www. TobaccoInAustralia.org.au. Accessed November 30, 2015.
55. Australian Institute of Health and Welfare [webpage on the Internet]. Asthma, Chronic Obstructive Pulmonary Disease and Other Respiratory Diseases in Australia. Cat. no. ACM 20. Canberra: AIHW; 2010. Available from: http: //www.aihw.gov.au/publications/index.cfm/ title/10518. Accessed May 23, 2012.
56. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012; 129 (4): 735-744.
57. Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med. 2003; 167 (6): 917-924.
58. Akuete K, Oh SS, Thyne S, et al. Ethnic variability in persistent asthma after in utero tobacco exposure. Pediatrics. 2011; 128 (3): e623-e630.
59. Glover M, Kira A, Faletau J. Smoke, smoking and cessation: the views of children with respiratory illness. J Asthma. 2013; 50 (7): 722-728.
60. Gritz ER, Vidrine DJ, Fingeret MC. Smoking cessation a critical component of medical management in chronic disease populations. Am J Prev Med. 2007; 33 (6 suppl): S414-S422.
61. Zwar N, Richmond R, Borland R, et al. Supporting Smoking Cessation: A Guide for Health Professionals. Melbourne: The Royal Australian College of General Practitioners; 2011.
62. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U. S. Department of Health and Human Services. Public Health Service; 2008.
63. Murray RL, Lewis SA, Coleman T, Britton J, McNeill A. Unplanned attempts to quit smoking: missed opportunities for health promotion? Addiction. 2009; 104 (11): 1901-1909.
64. Richter KP, Ellerbeck EF. It’s time to change the default for tobacco treatment. Addiction. 2015; 110 (3): 381-386.
65. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013; 8: CD002850.
66. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005; (2): CD001292.
67. Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2012; 12: CD009670.
68. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013; 5: CD000165.
69. Baxi R, Sharma M, Roseby R, et al. Family and carer smoking control programmes for reducing children’s exposure to environmental tobacco smoke. Cochrane Database Syst Rev. 2014; 3: CD001746.
70. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005; (2): CD001007.
71. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med. 1999; 106 (4): 410-416.
72. Karpinski JP, Timpe EM, Lubsch L. Smoking cessation treatment for adolescents. J Pediatr Pharmacol Ther. 2010; 15 (4): 249-263.
73. Tonnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res. 2005; 7 (1): 139-148.
74. West R, Owen L [homepage on the Internet]. Estimates of 52-Week Continuous Abstinence Rates Following Selected Smoking Cessation Interventions in England Version 2. 2012. Available from: www. smokinginengland.info. Accessed November 30, 2015.
75. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2011; (2): CD006103.
76. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014; 1: CD000031.
77. Flaherty D, Hoffman-Goetz L, Arocha JF. What is consumer health informatics? A systematic review of published definitions. Inform Health Soc Care. 2015; 40 (2): 91-112.
78. Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction. 2009; 104 (11): 1792-1804.
79. Wolfenden L, Wiggers J, Campbell E, Knight J, Kerridge R, Spigelman A. Providing comprehensive smoking cessation care to surgical patients: the case for computers. Drug Alcohol Rev. 2009; 28 (1): 60-65.
80. Boyle R, Solberg L, Fiore M. Use of electronic health records to support smoking cessation. Cochrane Database Syst Rev. 2011; (12): CD008743.
81. Gibbons MC, Wilson RF, Samal L, et al. Impact of consumer health informatics applications. Evid Rep Technol Assess. 2009; (188): 1-546.
82. An LC, Betzner A, Schillo B, et al. The comparative effectiveness of clinic, work-site, phone, and web-based tobacco treatment programs. Nicotine Tob Res. 2010; 12 (10): 989-996.
83. Civljak M, Stead LF, Hartmann-Boyce J, Sheikh A, Car J. Internetbased interventions for smoking cessation. Cochrane Database Syst Rev. 2013; 7: CD007078.
84. Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM. Effects of web-and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169 (10): 929-937.
85. Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009; 15 (3): 231-240.
86. Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemed J E Health. 2005; 11 (1): 28-35.
87. Rodgers A, Corbett T, Bramley D, et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control. 2005; 14 (4): 255-261.
88. Brendryen H, Kraft P. Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention. Addiction. 2008; 103 (3): 478-484.
89. Arrazola RA, Singh T, Corey CG, et al. Tobacco use among middle and high school students-United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2015; 64 (14): 381-385.
90. McNeill A, Brose LS, Caldar R, Hitchman SC, Hajek P, McRobbie H. E-Cigarettes: An Evidence Update. A Report Commissioned by Public Health England. 2015.
91. Polosa R, Morjaria J, Caponnetto P, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014; 11 (5): 4965-4977.
92. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014; 12: CD010216.
93. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146.
94. Centers for Disease Control and Prevention (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US); 2010.
95. Make B. Collaborative self-management strategies for patients with respiratory disease. Respir Care. 1994; 39 (5): 566-579. discussion 79-83.
96. Thomas D, Abramson M, Bonevski B, et al. Integrating smoking cessation into routine care in hospitals-a randomised controlled trial. Addiction. 2016; 111 (4): 714-723.
97. Grzeskowiak LE, Dekker G, Rivers K, et al. A randomized controlled trial to assess the clinical and cost effectiveness of a nurse-led Antenatal Asthma Management Service in South Australia (AAMS study). BMC Pregnancy Childbirth. 2014; 14: 9.
98. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006; 174 (2): 127-133.
99. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000; 161 (2 pt 1): 381-390.
100. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebocontrolled, randomised trial. Lancet. 2001; 357 (9268): 1571-1575.
101. Al-sheyab N, Gallagher R, Crisp J, Shah S. Peer-led education for adolescents with asthma in Jordan: a cluster-randomized controlled trial. Pediatrics. 2012; 129 (1): e106-e112.
102. Davis LJ Jr, Hurt RD, Offord KP, Lauger GG, Morse RM, Bruce BK. Self-administered Nicotine-Dependence Scale (SANDS): item selection, reliability estimation, and initial validation. J Clin Psychol. 1994; 50 (6): 918-930.
103. Shah S, Peat JK, Mazurski EJ, et al. Effect of peer led programme for asthma education in adolescents: cluster randomised controlled trial. BMJ. 2001; 322 (7286): 583-585.